faculty photo

Dina Jacobs, M.D.

Associate Professor of Neurology at the Hospital of the University of Pennsylvania
Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Neuroscience MS Disease Team Lead , Penn Medicine
Medical monitor , Penn Medicine Community Vaccine Clinics
Clinical Director, Center for Neuroinflammation and Experimental Therapeutics, Penn Medicine
Neurology Outpatient Director, HUP and PCAM, Penn Medicine
Department: Neurology

Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Office: (215) 662-3647
Fax: (215) 349-5579
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
University of Pennsylvania, 1996.
Post-Graduate Training
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
American Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
American Board of Psychiatry and Neurology; Recertification, 2022.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von Budingen HC, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A.: Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. PNAS 120(3): e2207291120, Jan 2023.

Lancet Neurology Editorial Board: Towards equitable access to treatment for multiple sclerosis (Editorial on Committee Report from Multiple Sclerosis International Federation Essential Medicines Panel Recommendations for Essential Medicines for the World Health Organization). The Lancet Neurology 2023.

Pfister A, Sweeney Smith M, Lane C, Desai N, Zimmerman, Jacobs D: The Impact and Feasibility of a Virtual Dance Program for Patients Living with MS. Consortium of MS Centers Annual Meeting, Denver, CO 2023.

Virupakshaiah A, Gill A, Schoeps V, Wilson E, Wilson J, Jacobs D, Do D, Berger J. : The Effect of Ocrelizumab on anti-JC Virus Antibody Index, B cells and immunoglobulins: a longitudinal study ACTRIMS, San Diego, CA 2023.

Multiple Sclerosis International Federation (MSIF), WHO Collaborating Centre in Evidence-Based Research Synthesis and Guideline Development : Proposal for inclusion of multiple sclerosis disease-modifying therapies (DMTs) on the complementary World Health Organization Model Lists of Essential Medicines. WHO EML website: https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/24th-eml-expert-committee/a10_ms-dmts 2023.

Anne Marie Radzik, Lilyana Amezcua, Annika Anderson, Serena Gilmore, Sophie Ahmad, Rachel Brandstadter, Michelle Fabian, Edith Graham, Sophia Hodgkinson, Lindsay Horton, Dina Jacobs, lana Katz Sand, Amit Kohli, Libby S. Levine, Monica McLemore, Annette Okai, Jasmin Patel, Shane Poole, Claire S. Riley, Sammita Satyanarayan, Lauren Tardo, Elizabeth Verter, Veronica Villacorta, Vanessa Zimmerman, Leah Zuroff, Mitzi Williams, Maria Houtchens, Riley Bove: Disparities by Race in Pregnancy Care and Clinical Outcomes in Women with MS: a Diverse, Multicenter Cohort American Academy of Neurology Annual Meeting, Boston, MA 2023.

Gandelman S, Thebault S, Zuroff L, Pileggi C, Markowitz C, Brandstadter R, Jacobs D: Neuroinvasive West Nile Virus in Association with Ocrelizumab Use in Multiple Sclerosis. ACTRIMS, San Diego, CA 2023.

Gandelman S, Stein L, Jacobs D: Feasibility of obtaining safety screening labs in an academic neurology clinic to accelerate time to anti-CD20 initiation. Consortium of MS Centers, Denver, CO 2023.

Erin Kim, BA, Lane Camryn, BS, Kristin McCabe, MSN, RN, CNRN, Stephanie Gandelman, MD, Noellie Rivera-Torres, MD, Mihir Kakara, MD, Rachel Brandstadter, MD, Chris Perrone, MD, Matthew Schindler, MD, PhD, Jennifer Orthmann-Murphy, MD, PhD, Clyde Markowitz, MD, Joseph Berger, MD, Amit Bar-Or, MD, Erin Perrone, BSN, RN, MSCN, Alison Noon, BSN, RN, Dawn Johnson, BSN, RN, MSCN, Angelica Carmolingo, BA, Ryan Fuller, PharmD, Kerry Lenzi, PharmD, Janice Lee, PharmD, Julie Mozes, BA, MBA, Lee Leibowitz, BS, MBA, Caitlin Pileggi, BSN, MSN, Meghan Garabedian, BSN, MSN, Sara Zeccardi, BSN, MSN, Nora Sekella, BA, MSW, Laura Stein, MD, Ray Price, MD, Dina Jacobs, MD: Penn Multiple Sclerosis and Related Disorders Center's Approach towards Addressing Disparities in Care in Resident Clinic. ANA Annual Meeting, Philadelphia, PA 2023.

Graham EL, Bakkensen JB, Anderson A, Lancki N, Davidson A, Perez Giraldo G, Jungheim ES, Vanderhoff AC, Ostrem B, Mok-Lin E, Huang D, Bevan CJ, Jacobs D, Kaplan TB, Houtchens MK, and Bove R.: Inflammatory Activity after Diverse Fertility Treatments: A Multicenter Analysis in the Modern MS Treatment Era. Neurology: Neuroimmunology & Neuroinflammation 10(3), 2023.

back to top
Last updated: 05/27/2023
The Trustees of the University of Pennsylvania